2:37 PM
 | 
Jun 11, 2018
 |  BC Extra  |  Company News

Management tracks: Arbutus, Cancer Research UK

HBV company Arbutus Biopharma Corp. (NASDAQ:ABUS) said CFO Koert VandenEnden is stepping down. He is succeeded by David Hastings, who was CFO and EVP at Unilife Corp....

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >